Bora Pharmaceuticals Co., LTD. (6472.TW)

TWD 744.0

(-0.67%)

Market Cap (In TWD)

76.49 Billion

Revenue (In TWD)

14.2 Billion

Net Income (In TWD)

3.03 Billion

Avg. Volume

1.93 Million

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
612.0-975.0
PE
-
EPS
-
Beta Value
0.695
ISIN
TW0006472004
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Pao-Shi Sheng
Employee Count
-
Website
https://www.bora-corp.com
Ipo Date
2023-12-11
Details
Bora Pharmaceuticals Co., LTD. researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide. The company operates through Sales, Contract Development & Manufacturing Organization, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services, including clinical and commercial manufacturing, pharmaceutical development, packaging and serialization, analytical and microbiology testing, and regulatory affairs services. In addition, it provides food and vitamin supplements, and skincare products; and biotechnical services. The company sells its products directly to clinics, pharmacies, pharmacy chains, and drug stores, as well as through distributors to medical centers, corporate and public hospitals, and regional and district hospitals. Bora Pharmaceuticals Co., LTD. was incorporated in 2007 and is based in Taipei City, Taiwan.